BrightView Health Lowell
-
Services:
- Sign language services for the deaf and hard of hearing
- Adult men
- Pregnant/postpartum women
- Adult women
- Prescribes naltrexone
- Buprenorphine detoxification
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Private for-profit organization
- The Joint Commission
- Substance use treatment
- Detoxification
- Cocaine Detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Benzodiazepines Detoxification
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- In-network prescribing entity
- In-network prescribing entity
- Young Adults
- Adults
- Individual counseling
- Substance use disorder education
- Group counseling
- Intensive outpatient treatment
- Outpatient
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient day treatment or partial hospitalization
- Regular outpatient treatment
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Drug or alcohol urine screening
- This facility administers/prescribes medication for alcohol use disorder
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Relapse prevention
- Cognitive behavioral therapy
- Community reinforcement plus vouchers
- Contingency management/motivational incentives
- Brief intervention
- Matrix Model
- Motivational interviewing
- Trauma-related counseling
- Screening for substance use
- Screening for tobacco use
- Comprehensive substance use assessment
- Medicare
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Medicaid
- Acamprosate (Campral®)
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Disulfiram
- Naltrexone (oral)
- Buprenorphine without naloxone
- Buprenorphine sub-dermal implant
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Smoking permitted in designated area
- Female
- Male
- Vaping permitted in designated area
- Social skills development
- Case management service
Language Services
Special Programs/Groups Offered
Type of Opioid Treatment
Facility Operation (e.g., Private, Public)
License/Certification/Accreditation
Type of Care
Detoxification (medical withdrawal) Services
Recovery Support Services
External Source of Medications Used for Alcohol Use Disorder Treatment
External Opioid Medications Source
Age Groups Accepted
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Transitional Services
Opioid Medications used in Treatment
Testing
Type of Alcohol Use Disorder Treatment
Treatment Approaches
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Pharmacotherapies
Facility Smoking Policy
Gender Accepted
Facility Vaping Policy
Ancillary Services






